122 related articles for article (PubMed ID: 31523619)
21. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
[TBL] [Abstract][Full Text] [Related]
22. Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism?
Ożegowska K; Bogacz A; Bartkowiak-Wieczorek J; Seremak-Mrozikiewicz A; Pawelczyk L
Ginekol Pol; 2016; 87(4):246-53. PubMed ID: 27321094
[TBL] [Abstract][Full Text] [Related]
23. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
24. Comparison of TaqMan Real-Time and Tetra-Primer ARMS PCR Techniques for Genotyping of Rs 8066560 Variant in Children and Adolescents with Metabolic Syndrome.
Miranzadeh-Mahabadi H; Miranzadeh-Mahabadi H; Nikpour P; Emadi-Baygi M; Kelishadi R
Adv Clin Exp Med; 2015; 24(6):951-5. PubMed ID: 26771965
[TBL] [Abstract][Full Text] [Related]
25. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.
Santos BR; Lecke SB; Spritzer PM
PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285
[TBL] [Abstract][Full Text] [Related]
26. The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome.
Koiou E; Tziomalos K; Dinas K; Katsikis I; Kalaitzakis E; Delkos D; Kandaraki EA; Panidis D
Endocr J; 2011; 58(4):237-46. PubMed ID: 21325745
[TBL] [Abstract][Full Text] [Related]
27. Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study.
Rueda-Gotor J; López-Mejías R; Remuzgo-Martínez S; Pulito-Cueto V; Corrales A; Lera-Gómez L; Portilla V; González-Mazón Í; Blanco R; Expósito R; Mata C; Llorca J; Hernández-Hernández V; Rodríguez-Lozano C; Barbarroja N; Castro RO; Vicente E; Fernández-Carballido C; Martínez-Vidal MP; Castro-Corredor D; Anino-Fernández J; Peiteado D; Plasencia-Rodríguez C; Galíndez-Agirregoikoa E; García-Vivar ML; Gualillo O; Quevedo-Abeledo JC; Castañeda S; Ferraz-Amaro I; González-Gay MÁ; Genre F
Arthritis Res Ther; 2021 Apr; 23(1):111. PubMed ID: 33849644
[TBL] [Abstract][Full Text] [Related]
28. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study.
Santos BR; Lecke SB; Spritzer PM
Reprod Biol Endocrinol; 2018 Apr; 16(1):38. PubMed ID: 29669566
[TBL] [Abstract][Full Text] [Related]
29. Association between serum vaspin level and metabolic syndrome in healthy Korean subjects.
Kim JM; Kim TN; Won JC
Metab Syndr Relat Disord; 2013 Dec; 11(6):385-91. PubMed ID: 23992351
[TBL] [Abstract][Full Text] [Related]
30. Circulating Adipokine VASPIN Is Associated with Serum Lipid Profiles in Humans.
Breitfeld J; Wiele N; Gutsmann B; Stumvoll M; Blüher M; Scholz M; Kovacs P; Tönjes A
Lipids; 2019 Apr; 54(4):203-210. PubMed ID: 30883766
[TBL] [Abstract][Full Text] [Related]
31. Human C-reactive protein gene polymorphism and metabolic syndrome are associated with premature coronary artery disease.
Abd El-Aziz TA; Mohamed RH
Gene; 2013 Dec; 532(2):216-21. PubMed ID: 24055729
[TBL] [Abstract][Full Text] [Related]
32. Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women.
Choi SH; Kwak SH; Lee Y; Moon MK; Lim S; Park YJ; Jang HC; Kim MS
Clin Endocrinol (Oxf); 2011 Nov; 75(5):628-35. PubMed ID: 21545478
[TBL] [Abstract][Full Text] [Related]
33. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
34. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome.
Cakal E; Ustun Y; Engin-Ustun Y; Ozkaya M; Kilinç M
Gynecol Endocrinol; 2011 Jul; 27(7):491-5. PubMed ID: 20626239
[TBL] [Abstract][Full Text] [Related]
35. Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease.
Parizadeh SA; Jamialahmadi K; Rooki H; Zaim-Kohan H; Mirhafez SR; Hosseini N; Mohiti-Ardakani J; Moohebati M; Masoudi-Kazemabad A; Ferns GA; Ghayour-Mobarhan M
Ann Hum Biol; 2015 Mar; 42(2):178-83. PubMed ID: 24897239
[TBL] [Abstract][Full Text] [Related]
36. Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components.
Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Mehegan J; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1386-94. PubMed ID: 20080841
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.
Kyrkou G; Trakakis E; Attilakos A; Panagopoulos P; Chrelias C; Papadimitriou A; Vaggopoulos V; Alexiou E; Mastorakos G; Lykeridou A; Kassanos D; Papaevangelou V; Papantoniou N
Arch Gynecol Obstet; 2016 Apr; 293(4):915-23. PubMed ID: 26615602
[TBL] [Abstract][Full Text] [Related]
38. Associations of the PTEN -9C>G polymorphism with insulin sensitivity and central obesity in Chinese.
Yang Q; Cao H; Xie S; Tong Y; Zhu Q; Zhang F; Lü Q; Yang Y; Li D; Chen M; Yu C; Jin W; Yuan Y; Tong N
Gene; 2013 Sep; 527(2):545-52. PubMed ID: 23796801
[TBL] [Abstract][Full Text] [Related]
39. The Relationship Between Vascular Endothelial Growth Factor Cis- and Trans-Acting Genetic Variants and Metabolic Syndrome.
Azimi-Nezhad M; Mirhafez SR; Stathopoulou MG; Murray H; Ndiaye NC; Bahrami A; Varasteh A; Avan A; Bonnefond A; Rancier M; Mehrad-Majd H; Herbeth B; Lamont J; Fitzgerald P; Ferns GA; Visvikis-Siest S; Ghayour-Mobarhan M
Am J Med Sci; 2018 Jun; 355(6):559-565. PubMed ID: 29891039
[TBL] [Abstract][Full Text] [Related]
40. Association between vaspin level and coronary artery disease in patients with type 2 diabetes.
Hao F; Zhang H; Zhu J; Kuang H; Yu Q; Bai M; Mu J
Diabetes Res Clin Pract; 2016 Mar; 113():26-32. PubMed ID: 26972957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
